Skip to main content

Table 1 Baseline characteristics of study participants

From: Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

Variables

NAFLD (n = 713)

Healthy controls (n = 304)

P value

 

Without MS (n = 413)

With MS (n = 300)

  

Age (yr)

45.9 ± 12.1

46.3 ± 12.2

46.3 ± 10.6

0.874

Gender (female/male)

132/281#

48/252*

110/194

<0.001

BMI (kg/m2)

25.9 ± 2.7*#

26.8 ± 2.5*

22.8 ± 2.6

<0.001

SBP (mmHg)

131± 16*

132 ± 16*

120 ± 14

<0.001

DBP (mmHg)

80 ± 11*

81 ± 11*

78 ± 10

<0.001

ALT (IU/L)

26 (7–179)*#

33 (9–184)*

17 (6–39)

<0.001

AST (IU/L)

24 (12–103)*#

26 (14–122)*

20 (12–38)

<0.001

γ-GT (IU/L)

29 (8–248)*#

41 (7–236)*

18 (7–50)

<0.001

TG (mmol/L)

1.32 (0.34–3.74)*#

2.26 (0.63-21.05)*

0.97 (0.39–1.70)

<0.001

TC (mmol/L)

4.91 ± 0.91*#

5.06 ± 1.06*

4.51 ± 0.63

<0.001

HDL-c (mmol/L)

1.24 ± 0.34*#

1.01 ± 0.24*

1.27 ± 0.28

<0.001

LDL-c (mmol/L)

2.74 ± 0.57*#

2.62 ± 0.64*

2.49 ± 0.44

<0.001

FPG (mmol/L)

5.21 (3.82–7.52)*#

5.43 (4.23–16.46)*

4.76 (3.81–6.08)

<0.001

Cr (μmol/L)

73 (37–104) #

76 (34–108)*

70 (40–104)

<0.001

UA (μmol/L)

351 (66–548)*#

381 (146–547)*

309 (171–422)

<0.001

Amylase (IU/L)

45 (21–207)*#

42 (21–102)*

53 (7–122)

<0.001

HbA1C (%)

5.6 (4.2–6.9)*#

5.7 (4.6–12.5)*

5.5 (3.2–6.3)

<0.001

HsCRP (mg/L)

1.4 (0.3–19.4)*#

1.6 (0.3–15.2)*

0.9 (0.2–8.8)

<0.001

PLT (109/L)

233 ± 52*

231 ± 55*

214 ± 41

<0.001

  1. Data are presented as mean ±SD or median (range).
  2. P value: compared among three groups.
  3. *p<0.05, compared with controls, #p<0.05, NAFLD without MS compared with NAFLD with MS.